CollPlant Biotechnologies (CollPlant Biotechnologies) EV-to-EBITDA : -25.48 (As of Apr. 26, 2024)

CollPlant Biotechnologies EV-to-EBITDA Chart

CollPlant Biotechnologies Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBITDA		Get a 7-Day Free Trial					-4.53	-15.20	162.93	-4.16	-7.75

CollPlant Biotechnologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															-4.16	-3.61	-12.64	-6.31	-7.75

Competitive Comparison of CollPlant Biotechnologies's EV-to-EBITDA

For the Biotechnology subindustry, CollPlant Biotechnologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CollPlant Biotechnologies's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's EV-to-EBITDA falls into.

CollPlant Biotechnologies EV-to-EBITDA Calculation

CollPlant Biotechnologies's EV-to-EBITDA for today is calculated as:

CollPlant Biotechnologies's current Enterprise Value is $163.35 Mil.
CollPlant Biotechnologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CollPlant Biotechnologies  (NAS:CLGN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CollPlant Biotechnologies's PE Ratio for today is calculated as:

CollPlant Biotechnologies's share price for today is $20.94.
CollPlant Biotechnologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.530.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

CollPlant Biotechnologies EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

CollPlant Biotechnologies (CollPlant Biotechnologies) Business Description